Path Lab-AI: An Autonomous Framework for Error-Free Histopathology Slide Interpretation

Year : 2026 | Volume : 13 | Issue : 01 | Page : 19 30
    By

    Khushi Verma,

  • Nitant Kumar,

  • Riya Singh,

  • Ajit Pal Singh,

  1. Student, Department of Pathology, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India
  2. Student, Department of Pathology, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India
  3. Student, Department of Pathology, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India
  4. Associate Professor, Department of Medical Lab Technology, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India

Abstract

Path Lab-AI represents a fully autonomous platform for the analysis of histopathology slides with circumscribed structures, designed to obtain highly accurate results using diagnostic methods and avoiding the usual limitations of standard microscopy-based pathology. Leveraging recent deep learning and whole slide image (WSI) analysis innovations, our system takes advantage of automated WSI ingestion along with pre-processing steps to account for staining variability, remove artifacts, and localize tissue from background. Such a hybrid convolutional and transformer backbone can capture local sensitivity to features (e.g., nuclear morphology) along with global structural context, enabling precise classification, segmentation, and detection through multi-task learning. Predictions generated by different individual models are then combined using an ensemble architecture, such as stacking, soft voting or weighted blending, accompanied with uncertainty quantification for assessing confidence. A self-supervised learning component that is trained on massive unlabeled WSI collection provides additional support to this method by reducing reliance on manual annotations and enhancing generalization. A multi-agent reasoning level is implemented based on consensus inference gradually fed with integrated medical knowledge norms (like clinical standards such as WHO classification and TNM staging) for guarding coherence and plausibility of findings. The system also features error detection and localization generating heat maps or attention masks to highlight confusing or low confidence areas, so a human can review if needed. The final output is compiled into structured diagnostic reports that follow guidelines, including quantitative measurements (such as tumor area and mitotic count) and visual overlays for improved interpretability. Connection with LIS/EHR via open protocols ensures a smooth introduction to the workflow. Path Lab-AI will aim for human-level diagnostic accuracy based on holistic evaluation across benchmark datasets, multicenter validation, and reader studies against trained pathologists with a focus on reproducibility and scalability. Through the integration of cutting-edge technology with appropriate clinical safety policies, it seeks to narrow inter-observer variability, enable faster diagnosis and democratize access to high-quality pathology services, eventually leading to standardized and qualitative histology on a worldwide basis.

Keywords: Artificial intelligence, CNN, deep learning, digital pathology, histopathology, vision transformer, whole slide imaging (WSI)

[This article belongs to Research & Reviews: A Journal of Bioinformatics ]

How to cite this article:
Khushi Verma, Nitant Kumar, Riya Singh, Ajit Pal Singh. Path Lab-AI: An Autonomous Framework for Error-Free Histopathology Slide Interpretation. Research & Reviews: A Journal of Bioinformatics. 2026; 13(01):19-30.
How to cite this URL:
Khushi Verma, Nitant Kumar, Riya Singh, Ajit Pal Singh. Path Lab-AI: An Autonomous Framework for Error-Free Histopathology Slide Interpretation. Research & Reviews: A Journal of Bioinformatics. 2026; 13(01):19-30. Available from: https://journals.stmjournals.com/rrjobi/article=2026/view=239689


References

  1. Swanson K, Wu W, Bulaong NL, Pak JE, Zou J. The virtual lab: AI agents design new SARS-CoV-2 nanobodies with experimental validation. bioRxiv. 2024:2024.11.
  2. Kon PTJ, Liu J, Zhu X, Ding Q, Peng J, Xing J, et al. EXP-Bench: Can AI conduct AI research experiments? arXiv [Preprint]. 2025;arXiv:2505.24785.
  3. McInnes LC, Arnold D, Balaprakash P, Bernhardt M, Cerny B, Dubey A, et al. Report of the 2025 workshop on next-generation ecosystems for scientific computing: Harnessing community, software, and AI for cross-disciplinary team science. arXiv [Preprint]. 2025;arXiv:2510.03413.
  4. Yang EW, Waldrup B, Velazquez-Villarreal E. From mutation to prognosis: AI-HOPE-PI3K enables artificial intelligence agent-driven integration of PI3K pathway data in colorectal cancer precision medicine. Int J Mol Sci. 2025;26(13):6487.
  5. Roussos G, Agorogianni A, Salmatzidis I, Tsiatsos T, Maltusch P, Renders E, et al. AI, digital transformation and governance: Mapping the landscape for the future of higher education communities. In: Proceedings of EUNIS Conference. 2025;107:21–39.
  6. Cresswell K, Williams R, Dungey S, Anderson S, Bernabeu MO, Mozaffar H, et al. A mixed methods formative evaluation of the United Kingdom National Health Service Artificial Intelligence Lab. NPJ Digit Med. 2025;8(1):448.
  7. Le Borgne F, Garnier C, Morisseau C, Navarrete Y, Echeverria Y, Mir J, et al. Structuring and centralizing breast cancer real-world biomarker data from pathology reports through the C-LAB artificial intelligence platform. Digit Health. 2025;11:20552076251323110.
  8. Giansanti D. Advancements in digital cytopathology since COVID-19: Insights from a narrative review of review articles. Healthcare (Basel). 2025;13(6):657.
  9. Javaid H, Petrescu CC, Schmunk LJ, Monahan JM, O’Reilly P, Garg M, et al. The impact of artificial intelligence on biomarker discovery. Emerg Top Life Sci. 2025;8(2):89–105.
  10. Burgess J, Nirschl JJ, Bravo-Sánchez L, Lozano A, Gupte SR, Galaz-Montoya JG, et al. MicroVQA: A multimodal reasoning benchmark for microscopy-based scientific research. In: Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR). 2025. p. 19552–19564.
  11. Aghakhanyan G, Barucci A, Pascali MA, Assante M, Bagnacci G, Bertelli E, et al. Navigator Consortium Group. NAVIGATOR: A regional multimodal imaging biobank initiative powered by AI tools for precision medicine in oncology. Eur J Radiol. 2025;172:112327.
  12. Slalmi A, Rabbah N, Battas I, Debbarh I, Medromi H, Abourriche A. Artificial intelligence-driven SELEX design of aptamer panels for urinary multi-biomarker detection in prostate cancer: A systematic and bibliometric review. Biomedicines. 2025;13(12):2877.
  13. Doloi S, Das M, Li Y, Cho ZH, Xiao X, Hanna JV, et al. Democratizing self-driving labs: Advances in low-cost 3D printing for laboratory automation. Digit Discov. 2025;4(7):1685–1721.
  14. Health Technology Assessment Group. Artificial intelligence-assisted clinician review of chest X-rays for suspected lung cancer. Health Technol Assess. 2025.
Regular Issue Subscription Original Research
Volume 13
Issue 01
Received 12/12/2025
Accepted 10/02/2026
Published 27/03/2026
Publication Time 105 Days
21

Login


My IP

PlumX Metrics